Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

131 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma

NCT07182565

Conditions
Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy
Locations
  • West China Xiamen Hospital, Sichuan University Xiamen, Fujian, China
  • The Seventh People's Hospital of Chengdu Chengdu, Sichuan, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
  • West China Shangjin Nanfu Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details
Recruiting

Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma

NCT07072351

Conditions
Chemotherapy, Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy, +1 more
Locations
  • West China Xiamen Hospital, Sichuan University Xiamen, Fujian, China
  • The Seventh People's Hospital of Chengdu Chengdu, Sichuan, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
  • West China Shangjin Nanfu Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details
Recruiting

Folfox+Irinotecan+Chemort In Esophageal Cancer

NCT04656041

Conditions
Esophagogastric Cancer, Gastroesophageal Junction Adenocarcinoma
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital at Newton Wellesley Hospital Newton, Massachusetts, United States
View Trial Details
Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

NCT03175224

Conditions
Advanced Cancer, Astrocytoma, Brain Diseases, +64 more
Locations
  • Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Moffitt Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View all 35 locations
View Trial Details

Related conditions